Entry |
|
Name |
EBV LMP1 to NFKB signaling pathway
|
Definition |
LMP1 -> (TRADD+TRAF6) -> (TAB1/2+TAK1) -> IKK -> NFKBIA -> NFKB |
Expanded |
K19459 -> (8717+7189) -> ((10454,23118)+6885) -> (1147+3551+8517) -> 4792 -> (4790+5970) |
Class |
|
Type |
Pathogen
|
Pathway |
|
Disease |
|
Gene |
8717 | TRADD; TNFRSF1A associated via death domain |
7189 | TRAF6; TNF receptor associated factor 6 |
10454 | TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 |
23118 | TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 |
6885 | MAP3K7; mitogen-activated protein kinase kinase kinase 7 |
1147 | CHUK; component of inhibitor of nuclear factor kappa B kinase complex |
3551 | IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta |
8517 | IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
4792 | NFKBIA; NFKB inhibitor alpha |
4790 | NFKB1; nuclear factor kappa B subunit 1 |
5970 | RELA; RELA proto-oncogene, NF-kB subunit |
|
Perturbant |
K19459 (LMP1) | LMP1; EBV latent membrane protein 1 |
|
Reference |
|
Authors |
Ersing I, Bernhardt K, Gewurz BE |
Title |
NF-kappaB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1. |
Journal |
|
Reference |
|
Authors |
Dawson CW, Port RJ, Young LS |
Title |
The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). |
Journal |
|
Reference |
|
Authors |
Wang LW, Jiang S, Gewurz BE |
Title |
Epstein-Barr Virus LMP1-Mediated Oncogenicity. |
Journal |
|
Reference |
|
Authors |
Mori N, Morishita M, Tsukazaki T, Yamamoto N |
Title |
Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB. |
Journal |
|
Reference |
|
Authors |
Edwards RH, Marquitz AR, Raab-Traub N |
Title |
Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3. |
Journal |
|
LinkDB |
|